TP 0903 is a drug used to treat Advanced Solid Tumors, BRAF-Mutated Melanoma, CLL, and other conditions. TP 0903 is being actively studied in 1 study; no studies for this drug have been completed so far.
|Top Sponsors||Top Sites||Top Investigators|
|Sumitomo Pharma Oncology, Inc.||Mayo Clinic Arizona|
|Mayo Clinic Florida|
|Mayo Clinic Rochester|